Smith Todd N
EVP & Chief Commercial Officer at HORIZON PHARMA, INC.
- Sold, on record
- $226k
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 19, 2014
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- HORIZON PHARMA, INC.EVP & Chief Commercial Officer
Sales by reason
0
Routine
3
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- May 19, 2014Plan not stated
Sold 18.6% of their holdings
$131k10,159 shares at $12.94
- Dec 9, 2013Plan not stated
Sold 21.7% of their holdings
$78k11,322 shares at $6.91
- Jan 2, 2013Plan not stated
Sold 23.7% of their holdings
$17k6,998 shares at $2.36
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Aug 10, 2026 | LTGO | Director | AwardedDirector Stock Option (right to buy) | 105,542 | 105,542 | SEC | ||
| May 20, 2020 | May 22, 2020 | Assertio Holdings, Inc. | Director, Pres & CEO | AwardedStock Option (right to buy) | 1.1M | 450,000 | SEC | ||
| May 20, 2020 | May 22, 2020 | Assertio Holdings, Inc. | Director, Pres & CEO | Awarded | 644,925 | 644,925 | SEC | ||
| May 20, 2020 | May 21, 2020 | Egalet Corp | President and CEO | Returned to the companyStock Option (right to buy) | 421,500 | 0 | SEC | ||
| May 20, 2020 | May 21, 2020 | Egalet Corp | President and CEO | Returned to the company | 365,500 | 0 | SEC | ||
| Mar 4, 2020 | Mar 5, 2020 | Egalet Corp | President and CEO | AwardedStock Option (right to buy) | 241,500 | 241,500 | SEC | ||
| Mar 4, 2020 | Mar 5, 2020 | Egalet Corp | President and CEO | Awarded | 165,500 | 165,500 | SEC | ||
| Jan 2, 2020 | Jan 2, 2020 | Egalet Corp | President and CEO | AwardedStock Option (right to buy) | 180,000 | 180,000 | SEC | ||
| Oct 23, 2019 | Oct 24, 2019 | Egalet Corp | President and CEO | Awarded | 200,000 | 200,000 | SEC | ||
| Jan 2, 2015 | Jan 6, 2015 | IVERIC bio, Inc. | SVP & CCO | AwardedStock Option (Right to Buy) | 6,900 | 1,400 | SEC | ||
| Oct 3, 2014 | Oct 7, 2014 | IVERIC bio, Inc. | SVP & CCO | AwardedStock Option (Right To Buy) | 150,000 | 150,000 | SEC | ||
| Sep 19, 2014 | Sep 22, 2014 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | AwardedStock Option (Right to Buy) | 281,784 | 62,000 | SEC | ||
| Sep 19, 2014 | Sep 22, 2014 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Awarded | 54,138 | 54,138 | SEC | ||
| Sep 19, 2014 | Sep 22, 2014 | HORIZON PHARMA, INC. | EVP, Chief Commercial Officer | Returned to the companyStock Option (Right to Buy) | 281,784 | 0 | SEC | ||
| Sep 19, 2014 | Sep 22, 2014 | HORIZON PHARMA, INC. | EVP, Chief Commercial Officer | Returned to the company | 54,138 | 0 | SEC | ||
| May 19, 2014 | May 21, 2014 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Sold | 10,159 | $12.94 | $131k | 44,552 | SEC |
| Jan 2, 2014 | Jan 10, 2014 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | AwardedEmployee stock options (right to buy) | 132,000 | 62,000 | SEC | ||
| Dec 9, 2013 | Dec 9, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Sold | 11,322 | $6.91 | $78k | 40,961 | SEC |
| Dec 9, 2013 | Dec 9, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Exercised or settledRestricted stock units | 3,350 | 6,698 | SEC | ||
| Dec 9, 2013 | Dec 9, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Exercised options | 3,350 | 52,283 | SEC | ||
| Dec 5, 2013 | Dec 9, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Awarded | 18,037 | 48,933 | SEC | ||
| Jan 2, 2013 | Jan 3, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Sold | 6,998 | $2.36 | $17k | 22,570 | SEC |
| Jan 2, 2013 | Jan 3, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | AwardedEmployee stock options (right to buy) | 116,000 | 55,000 | SEC | ||
| Dec 31, 2012 | Jan 3, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Awarded | 22,500 | 29,568 | SEC | ||
| Dec 10, 2012 | Dec 12, 2012 | HORIZON PHARMA, INC. | SVP, Marketing & Alliance Mgmt | Exercised or settledRestricted stock units | 3,349 | 10,048 | SEC | ||
| Dec 10, 2012 | Dec 12, 2012 | HORIZON PHARMA, INC. | SVP, Marketing & Alliance Mgmt | Exercised options | 3,349 | 7,068 | SEC | ||
| Dec 8, 2011 | Dec 9, 2011 | HORIZON PHARMA, INC. | SVP, Marketing & Alliance Mgmt | AwardedEmployee stock options (right to buy) | 35,277 | 13,397 | SEC |
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2014 | May 21, 2014 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Form 4 sale | 10,159 | $131k | 18.6% | Plan not stated | SEC |
| Dec 9, 2013 | Dec 9, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Form 4 sale | 11,322 | $78k | 21.7% | Plan not stated | SEC |
| Jan 2, 2013 | Jan 3, 2013 | HORIZON PHARMA, INC. | EVP & Chief Commercial Officer | Form 4 sale | 6,998 | $17k | 23.7% | Plan not stated | SEC |